Looking Ahead The increasing popularity of GLP-1 agonists outside traditional diabetic populations means emergency physicians will continue to see complications from these agents
Furthermore, in the MDL involving Ozempic and other GLP-1 medications, the U.S
Interestingly, patients with euglycemic DKA may have a normal mental status despite marked ketoacidosis, and vomiting seems to be a common complaint
In the future, the researchers hope to clarify the long-term impact of GLP-1 medications, the HFpEF subpopulations that may derive the most benefit from them, and whether the drugs are also effective in reducing other cardiovascular risks
The other produced nearly double the weight loss in clinical trials but remains years away from FDA approval
Lifestyle factors like sleep, diet, and activity also influence outcomes